Johnson & Johnson Total Liabilities increased by 1.7% to $119.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.6%, from $115.56B to $119.71B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows relatively stable performance with a 1.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $106.86B | $108.96B | $108.00B | $103.65B | $101.37B | $100.53B | $110.57B | $125.10B | $115.28B | $94.83B | $98.78B | $101.95B | $109.55B | $108.13B | $108.61B | $115.56B | $114.92B | $113.54B | $117.67B | $119.71B |
| QoQ Change | — | +2.0% | -0.9% | -4.0% | -2.2% | -0.8% | +10.0% | +13.1% | -7.9% | -17.7% | +4.2% | +3.2% | +7.5% | -1.3% | +0.4% | +6.4% | -0.6% | -1.2% | +3.6% | +1.7% |
| YoY Change | — | — | — | — | -5.1% | -7.7% | +2.4% | +20.7% | +13.7% | -5.7% | -10.7% | -18.5% | -5.0% | +14.0% | +10.0% | +13.4% | +4.9% | +5.0% | +8.3% | +3.6% |